CPT2 rs1057517477: Understanding This Rare Genetic Variant
The rs1057517477 variant is located within the CPT2 gene, which plays a critical role in how the body processes long-chain fatty acids for energy. This specific variant is considered rare and is studied in the context of metabolic health and mitochondrial function.
What each genotype means
Heterozygous insertion carrier
You carry one copy of the CTTT insertion and one copy of the typical sequence at this position. Current research does not indicate that this specific insertion significantly alters CPT2 function, but it is classified as a rare variant in population databases.
This genotype is rare and observed at very low frequencies in global population datasets.
Homozygous insertion carrier
You carry two copies of the CTTT insertion at this location. While this variant is documented in clinical databases, there is currently limited evidence to suggest it causes significant changes to fatty acid oxidation or metabolic health.
This genotype is extremely rare and is only occasionally reported in large-scale genomic studies.
What is the rs1057517477 Variant?
The rs1057517477 variant is a specific change in the DNA sequence of the CPT2 gene. In genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular variant is cataloged in public databases as a rare genetic marker. Because it is located within the CPT2 gene, researchers are interested in whether it influences the production or function of the CPT2 protein. It is important to note that the presence of a variant does not automatically imply a health condition; many variants are neutral and have no observable effect on human biology. Scientists use these markers to map the human genome and understand the diversity of genetic traits across different populations.
The Role of the CPT2 Gene
The CPT2 gene provides instructions for making an enzyme called carnitine palmitoyltransferase 2. This enzyme is located in the inner membrane of mitochondria, the powerhouses of our cells. Its primary job is to help transport long-chain fatty acids into the mitochondria so they can be broken down, or oxidized, to produce energy. This process is especially vital during periods of metabolic stress, such as fasting or intense physical exercise, when the body relies heavily on fat stores for fuel. When the CPT2 enzyme does not function correctly, it can lead to a group of conditions known as CPT II deficiency. These conditions range from mild, adult-onset muscle pain to severe, life-threatening forms that appear in infancy. Understanding the CPT2 gene is essential for grasping how our bodies manage energy production at a cellular level.
Research and Evidence
Current research into the CPT2 gene focuses heavily on its role in fatty acid oxidation disorders. While certain pathogenic mutations in CPT2 are well-documented as causes of CPT II deficiency, the clinical significance of many other variants, including rs1057517477, remains a subject of ongoing investigation. Evidence for this specific variant is currently limited, and it is not widely classified as a primary driver of disease in the same way as known pathogenic mutations. In the scientific community, evidence strength for such variants is often categorized as moderate or low until large-scale studies can confirm a consistent association with specific traits or health outcomes. Researchers continue to analyze genomic data to determine if this variant contributes to metabolic variability or if it is simply a benign piece of genetic background.
Population Frequency
The rs1057517477 variant is classified as rare in human populations. Genetic databases indicate that it does not appear frequently across major ancestral groups, which is common for many variants identified in the CPT2 gene. Because it is rare, it is difficult to draw broad conclusions about its distribution or its potential impact on health across different ethnicities. Most individuals will not carry this specific variant, and its rarity means that large-scale population studies are required to fully understand its prevalence and any potential associations with metabolic traits.
What You Can Do With This Information
If you have identified this variant in your genetic data, it is important to maintain perspective. Most genetic variants are neutral and do not cause health issues. This information is primarily for educational purposes and should not be used to diagnose or treat any medical condition. If you have concerns about your metabolic health, energy levels, or family history of muscle-related disorders, the best course of action is to consult with a healthcare professional or a genetic counselor. They can provide context based on your personal health history and clinical symptoms. Never make changes to your diet, exercise routine, or medication based on a single genetic variant without professional guidance. Always discuss any health-related questions with your clinician or pharmacist, who can help you interpret your results in the context of your overall well-being.
How common is this variant?
The rs1057517477 variant is documented as rare in global population databases, meaning it is found in only a very small percentage of individuals.
Frequently asked questions
Is rs1057517477 a disease-causing mutation?
There is currently no evidence to suggest that this specific variant is a primary cause of disease. It is classified as a rare variant, and its clinical significance remains under investigation.
Does this variant affect my ability to exercise?
There is no established link between this variant and exercise performance. If you experience unusual muscle pain or weakness during exercise, you should speak with a doctor to investigate the cause.
Should I be worried if I have this variant?
No. Most genetic variants are harmless, and having a rare variant does not mean you have a health condition. Focus on overall health and consult a professional if you have specific medical concerns.
Where can I learn more about CPT2?
You can find reliable information on the CPT2 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and associated conditions.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1057517477?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CPT2
This variant is associated with stress-induced myopathic forms of Carnitine palmitoyltransferase II deficiency.
Pathogenic missense variant (p.Ser113Leu) in CPT2 causing carnitine palmitoyltransferase II deficiency, predominantly the adult myopathic form.